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Abstract 
Chronic helminth infection with Schistosoma (S.) mansoni protects against allergic airway 
inflammation (AAI) in mice and is associated with reduced Th2 responses to inhaled 
allergens in humans, despite the presence of schistosome-specific Th2 immunity. 
Schistosome eggs strongly induce type 2 immunity and allow to study the dynamics of Th2 
versus regulatory responses in the absence of worms. Treatment with isolated S. mansoni 
eggs by i.p. injection prior to induction of AAI to ovalbumin (OVA)/alum led to significantly 
reduced AAI as assessed by less BAL and lung eosinophilia, less cellular influx into lung 
tissue, less OVA-specific Th2 cytokines in lungs and lung-draining mediastinal lymph nodes, 
and less circulating allergen-specific IgG1 and IgE antibodies. While OVA-specific Th2 
responses were inhibited, treatment induced a strong systemic Th2 response to the eggs. The 
protective effect of S. mansoni eggs was unaltered in µMT mice lacking mature (B2) B cells, 
and unaffected by Treg cell depletion using anti-CD25 blocking antibodies during egg 
treatment and allergic sensitization. Notably, prophylactic egg treatment resulted in a reduced 
influx of pro-inflammatory, monocyte-derived dendritic cells into lung tissue of allergic mice 
following challenge. Altogether, S. mansoni eggs can protect against the development of 
AAI, despite strong egg-specific Th2 responses.      
          
Keywords 
Asthma, Allergy and Immunology, Helminths, Schistosoma mansoni, Th2 cells, B 
lymphocytes, Antigen-presenting cells 
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Introduction 
The prevalence of allergies and asthma has dramatically increased in developed countries 
over the last decades, and the incidence rates continue to increase especially in low and 
middle-income countries (1). It has been suggested that environmental factors, such as an 
increased exposure to air pollutants and tobacco smoke (2), but also an overly sanitary life-
style, with decreased exposure to parasites, may play an important role in the increased 
prevalence of asthma.  
 
The protective effect of parasitic infections against allergic asthma has been introduced as 
one of many elements in the so-called “old friends hypothesis” (3-6). The relationship 
between helminths and asthma is complex, with factors such as worm species, timing, 
intensity and chronicity of infection as well as host genetics at interplay (7), and a causal link 
in humans has yet to be demonstrated. Acute or light helminth infections seem to promote 
allergic sensitization and allergic symptoms, while chronic helminth infections are more often 
associated with protection (7, 8). This may also explain why deworming at population level 
has been shown to result in enhanced skin-prick test positivity or rates of eczema in some 
cases, while having no effect in others (8). A large body of epidemiological and experimental 
studies has shown that, despite heterogeneity in the results, especially hookworm infections 
have been consistently found to reduce allergic sensitization (9, 10). Schistosoma ssp. has 
also been reported to be protective against allergic sensitization in humans (9, 11).  
 
Schistosoma ssp. infections consist of an acute phase dominated by a strong Th2 response to 
the eggs, and a chronic phase with a diminished Th2 response and increased activity of 
regulatory immune cells (12). To distinguish between egg-induced and worm-induced 
protection from AAI, experimental infections with mixed sex or male Schistosoma worms 
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were performed (13-19). However, these reports revealed conflicting results, as some 
indicated a reduction in AAI in the presence of egg-producing infections (14, 16, 18, 19) 
whereas others showed a reduction in the absence of eggs (13, 17). In addition, some studies 
show protection from AAI during the acute (5-11 weeks) (17, 19), and others during the 
chronic (12-16 weeks) (14, 18) phase of infection, which elicit characteristically different 
immune responses. 
 
From an immunological perspective, the conundrum that Th2-inducing helminth infections 
can dampen symptoms linked to allergic Th2 responses as observed in humans and mouse 
models (7, 8) is still subject to discussion. Often, the immunomodulatory activity of 
helminths is associated to the induction of a regulatory network. In mouse models, the rodent 
nematodes Heligmosomoides polygyrus and Nippostrongylus brasiliensis revealed important 
insights into the role of regulatory T (Treg) (20) and B (Breg) (21) cells as well as the 
regulatory cytokine IL-10 (22, 23) in protection against AAI. Treg and Breg cells as well as 
IL-10 have also been described to mediate protection induced by S. mansoni infections (14, 
16-19). However, data showing that the acute phase S. mansoni infections and/or the presence 
of eggs are important for protection suggests that the induction of a regulatory network is not 
the sole determinant of immunomodulation. 
 
To further explore the dynamics and interplay between Th2 responses and regulatory 
responses in the protective effect of S. mansoni infections against AAI, we used isolated eggs 
instead of a full natural infection. We show that eggs are equally protective as a natural S. 
mansoni infection in a prophylactic setting, despite the induction of a strong egg-specific Th2 
response. Egg treatment did not lead to Treg cell expansion or enhanced activity markers 
following allergen challenge and The observed protection was independent of both Treg cells 
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and B cells. Instead, S. mansoni egg-induced protection was associated with a reduced 
pulmonary influx of pro-inflammatory monocyte-derived dendritic cells (moDCs). This study 
shows that, although inducing egg-specific Th2 responses, S. mansoni eggs can protect from 
AAI, closely resembling the human situation.  
 
Material and Methods 
Mice 
Female C57BL/6 mice (Harlan) were housed under SPF conditions in the animal facility of 
the Leiden University Medical Center (Leiden, The Netherlands) and used for experiments at 
6-12 weeks of age. All animal studies were performed in accordance with the Animal 
Experiments Ethical Committee of the Leiden University Medical Center. The Dutch 
Experiments on Animals Act is established under European Guidelines (EU directive no. 
86/609/EEC regarding the Protection of Animals used for Experimental and Other Scientific 
Purposes). B6.129S2-Ighmtm1Cgn/J (μMT) mice (C57BL/6 background) were kindly 
provided by B. Lambrecht, Ghent University (Belgium) and originally purchased from 
Jackson Laboratory (Bar Harbor, USA).  
 
Preparation of S. mansoni eggs 
Eggs were isolated from trypsinized livers of hamsters infected for 50 days with a Puerto 
Rican-strain of S. mansoni, washed with RPMI medium containing 300U/mL penicillin, 
300μg/mL streptomycin (both Sigma-Aldrich) and 500μg/mL amphotericin B (ThermoFisher 
Scientific) and frozen at -80ºC until use. To investigate whether freeze-thawed eggs still 
release a comparable protein content to that of freshly cultured eggs, excretory-secretory 
product (eggES) of freeze-thawed and fresh eggs was compared by silver staining after 48h 
of egg culture. 
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Allergic airway inflammation model, egg treatment and Treg cell depletion 
Mice were sensitized by i.p. injection of OVA (10μg/mL; Invivogen) emulsified in alum 
adjuvant (2mg/mL; ThermoFisher Scientific) on day 0 and 7. Seven to 10 days after the last 
injection, mice were challenged for 3 consecutive days by either exposure to OVA aerosols 
(10mg/mL in PBS, 30mins), or by intranasal (i.n.) administration of 50μg OVA/50μL PBS. 
Mice were sacrificed 24 hours after the last challenge. Animals in the treatment group 
received two i.p. injections of 5000 S. mansoni eggs diluted in sterile PBS in on day 11 and 
day 4 prior to allergic sensitization. To deplete Treg cells, mice were treated i.p. with anti-
CD25 depleting (clone PC61) or control (anti-β-galactosidase, clone GL113) antibody 
(500µg/mouse) 6 days prior to the first egg injection and again 6 days prior to the first 
allergic sensitization (2 days before second egg injection)(24). 
 
Tissue preparation 
BAL fluid was collected by flushing the lungs with 1mL PBS/2mM EDTA (Invitrogen), 
followed by additional two lavages to collect remaining cells. The 1
st
 BAL flush was kept 
separate for cytokine analysis in cell-free supernatant, the cells from all flushes were pooled 
for flow cytometry. Perfused lungs were cut into small pieces and digested using collagenase 
III (100U/mL; Worthington) and DNAse (2000U/mL; Sigma-Aldrich) for 1 hour at 37ºC. 
Digested lungs were homogenized through 70μm cell strainers (BD Biosciences) and 
remaining red blood cells lysed. In some cases, one side of the lung was tied off with surgical 
suture and removed, and the other side inflated with and collected into 3.9% PFA/PBS. 
Mediastinal lymph nodes and spleens were homogenized through 70μm filters, and spleens 
were subjected to red blood cell lysis. Blood for assessment of Treg cells was collected from 
the tail vein 6 days after the first injection of anti-CD25 or control antibody and red blood 
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cells were lysed. For serum collection, blood was collected by heart puncture, spun down and 
the serum stored at -20ºC until further analysis. 
 
Flow cytometry 
The cellular composition of BAL fluid was determined by staining with fluorescently labelled 
antibodies against B220 (RA3-6B2), CD3 (17A2), CD11b (M1/70), CD11c (HL3), Gr-1 
(RB6-8C5), MHCII (M5/114.15.2) and Siglec-F (E50-2440) directly ex vivo. Treg cells in 
BAL fluid, medLNs and blood were identified by staining with live/dead fixable aqua dead 
cell stain kit (ThermoScientific) and fluorescently labelled antibodies against CD3 (17A2), 
CD4 (GK1.5), CD25 (PC61.5), CTLA-4 (UC10-4B9), Foxp3 (FJK-16s) and GITR (YGITR 
765). DCs in lung tissue were identified by staining with live/dead fixable aqua dead cell 
stain kit (ThermoScientific) and fluorescently labelled antibodies against CD3 (17A2), 
CD11b (M1/70), CD11c (HL3), CD19 (MB19-1), CD64 (X54-5/7.1), CD103 (2E7), Gr-1 
(RB6-8C5), MHCII (A5/114.15.2), Nk1.1 (PK136) and Siglec-F (E50-2440). For all 
stainings, FcγR-binding inhibitor (2.4G2, kind gift of L. Boon, Bioceros) was added. Flow 
cytometry was performed using a FACS Canto II and FACSDiva software (BD Biosciences) 
followed by data analysis using FlowJo.  
 
Histology 
Lungs were collected into 3.9% PFA/PBS and the tissue transferred into 70% ethanol after 1-
2 days. Lungs were then embedded in paraffin, sliced and stained for inflammatory cell 
infiltration using haematoxylin and eosin (H&E; both Klinipath). Stained slices were 
analysed under a Olympus BX41 light microscope (Olympus). Peribronchial inflammation as 
assessed by H&E staining was scored on a scale 0-4 by two blinded, independent 
investigators. 
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ELISA and CBA 
OVA- and SEA-specific IgG1 and IgE antibodies were measured in serum. 96-well Nunc 
Maxisorp plates (ThermoFisher Scientific) were coated with 25μg/mL of the respective 
antigen diluted in buffer (1M sodium carbonate) at 4ºC overnight and subsequently incubated 
with serial dilutions of sera, biotinylated detection antibodies against IgG1 and IgE (BD 
Biosciences) and horseradish peroxidase-conjugated streptavidin (BD Biosciences). Optical 
densities were measured after addition of TMB peroxidase substrate (KPL). The 
concentration of the cytokines IL-5, IL-10, IL-13 and IFN-γ were detected in cell-free 
supernatants of BAL fluid and cell cultures using either ELISA kits or BD cytometric bead 
array (CBA) Flex-set kits (BD Biosciences) followed by flow cytometry measurement on a 
FACS Canto II (BD Biosciences). The chemokine CCL2 was also measured using a CBA 
Flex-set kit.  
 
Statistical analysis 
Statistical analysis was performed with GraphPad Prism (version 7.02) using unpaired t-test 
for comparison of 2 groups, one-way ANOVA for comparison of more than two groups, and 
two-way ANOVA for comparison of more than two groups while correcting for a batch effect 
between different experiments. All data are presented as mean ± standard error of the mean 
(SEM). P-values < 0.05 were considered statistically significant.  
 
Results 
S. mansoni eggs protect against OVA/alum-induced AAI  
We and others have previously reported that chronic, but not acute, mixed infection with S. 
mansoni, which most closely resembles the natural situation in humans, protects mice from 
allergic airway inflammation (14, 16, 18, 19). A plausible explanation for the differential 
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effect of acute and chronic infection might be the changing balance between Th2 and 
regulatory responses. To further explore the dynamics and interplay between Th2 and 
regulatory responses in helminth infections, we first tested whether S. mansoni liver-derived 
eggs can confer protection from AAI in the absence of worms. These eggs were isolated from 
livers of infected hamsters and frozen prior to use. We have confirmed that the excretory-
secretory product (eggES) of these freeze-thawed eggs is similar to that of freshly isolated, 
mature liver eggs (suppl. Figure 1 A). Mice were treated twice with 5x10
3
 eggs by i.p. 
injection prior to allergic sensitization with OVA emulsified in alum adjuvant (Figure 1 A). 
This treatment resulted in a profound suppression of overall cellularity and eosinophilia both 
in the bronchoalveolar lavage (BAL) fluid (Figure 1 B) and in lung tissue (suppl. Figure 1 
B), accompanied by a reduction in various other leukocyte populations (Figure 1 C). The 
reduction in AAI in treated mice was also reflected by the reduction of cellular infiltration 
around the airways (Figure 1 D) as assessed by histology. Assessment of serum 
immunoglobulins revealed that egg treatment ablates the OVA-specific IgG1 and IgE 
response (Figure 1 E). We also assessed local cytokine production in BAL fluid, as well as 
local recall responses to the allergen by restimulation of medLN with OVA. In both BAL 
fluid and OVA-restimulated medLN cell cultures, the production of allergic Th2 cytokines 
IL-5 and IL-13 was greatly increased in allergic mice, but blocked upon egg treatment 
(Figure 1 F, G). IL-10, whilst not detectable in BAL fluid, followed the same pattern as IL-5 
and IL-13 in OVA-restimulated medLN cell cultures (Figure 1 G). Additionally, IFN-γ could 
hardly be detected in both BAL fluid and OVA-restimulated medLN cell cultures (Figure 1 
F, G). Collectively, these data show that S. mansoni egg administration prior to allergic 
sensitization inhibits the development of OVA-induced AAI. 
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Protection occurs despite the induction of an egg-specific Th2 response 
Human and animal hosts are known to mount a strong type 2 immune responses to egg 
deposition in live infections. To determine whether egg treatment induced a systemic, 
antigen-specific cytokine response in our model, we restimulated spleen cell cultures with 
soluble egg antigens (SEA). SEA restimulation profoundly increased the production of IL-5, 
IL-10 and IL-13, but not IFN-γ, in mice that had received isolated eggs compared to naïve or 
allergic, untreated mice (Figure 2 A). In the medLN similar cytokine profiles were observed 
following SEA restimulation (suppl. Figure 2). Furthermore, OVA-restimulated spleen cell 
cultures induced a strong Th2 cytokine production in the allergic group (Figure 2 B). 
Strikingly, these data show a systemic inhibition of OVA-specific type 2 immunity, in 
addition to the local inhibition observed in Figure 1. Additionally, high levels of IgG1 were 
observed, however the SEA-specific IgE response was found to be weak (Figure 2 C). These 
data show that egg treatment induces a fully developed Th2 response to egg antigens in the 
absence of an allergic Th2 response to OVA. 
 
Egg-induced protection against AAI is independent of Treg cells 
S. mansoni infection (16, 19) and antigens (25, 26) have been described to induce Treg cells 
in mice and humans. Therefore, we addressed whether egg treatment enhanced the number or 
activation state of Treg cells following allergen challenge in our model. The frequency and 
number of Treg cells were significantly increased in the BAL fluid of allergic mice, but 
remained at baseline in mice treated with eggs (Figure 3 A). While the frequency of Treg 
cells remained unchanged in the medLNs, total numbers increased in allergic mice 
irrespective of egg treatment (Figure 3 B). Additionally, in allergic animals extracellular 
regulatory markers CTLA-4 and GITR showed enhanced expression on Treg cells in the 
BAL (Figure 3 C) and medLNs (Figure 3 D), but were not further increased by egg 
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treatment. To further dissect the role of Treg cells in egg-mediated suppression, we depleted 
Treg cells by means of monoclonal, anti-CD25 depleting antibodies (clone PC61) during egg 
treatment and allergic sensitization (Figure 3 E). Successful depletion of Treg cells was 
confirmed by flow cytometry (suppl. Figure 3 A). Mice depleted of CD25-expressing Treg 
cells still displayed significantly reduced BAL cellularity and number of BAL eosinophils 
comparable to control mice treated with antibodies against anti-β-galactosidase (anti-βGAL) 
(Figure 3 F), as well as reduced numbers of neutrophils (Figure 3 G). In contrast, in egg-
treated mice Treg cell depletion did seem to affect the number of DCs, T cells and B cells in 
the BAL fluid at least to some extent, as their numbers were increased and not significantly 
different anymore between allergic controls and egg-treated mice (Figure 3 G). We observed 
a similar trend in the secretion of type 2 cytokines IL-5 and IL-13 in BAL fluid following 
Treg cell depletion, which were restored compared to those in allergic control mice (Figure 
3H). These data may suggest a selective effect on the lung T cell compartment following 
anti-CD25 treatment, resulting in enhanced T cell activation. Although there is a general 
trend towards increased airway inflammation following anti-CD25 treatment in both allergic 
control and egg-treated mice, this effect seems to be more pronounced in the egg-treated 
group with respect to the lung T cell compartment. Anti-CD25 treatment did however not 
restore eosinophilic inflammation in egg-treated mice. Collectively, these data suggest that 
depletion of Treg cells does not have a major influence on inhibition of AAI by egg treatment 
and thus cannot explain egg-induced protection against AAI.Mature B cells are not crucial 
for egg-induced protection against AAI 
 
In addition to Treg cells, we also sought to investigate the role of B cells in egg-induced 
protection against AAI. B cells possess various functions ranging from antibody production, 
formation of memory and antigen presentation to the production of pro- and anti-
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inflammatory cytokines. The production of regulatory cytokines such as IL-10, and the 
production of inhibitory immunoglobulins are the widely recognized regulatory functions 
exerted by B cells (27). Here, we used μMT mice, which lack mature (B2) B cells (28), to test 
whether B cells are required for the protective effect observed on OVA/alum-induced AAI 
after egg treatment. Both WT and μMT mice responded equally to induction of AAI as 
shown by total BAL cellularity and the presence of eosinophils in BAL fluid (Figure 4 A). 
Egg treatment significantly inhibited eosinophilia both in WT and μMT mice (Figure 4 A), 
and a similar pattern could be observed for BAL neutrophils, DCs and T cells (Figure 4 B). 
Additionally, while B cells sharply increased in WT mice and decreased with egg treatment, 
the number of B cells was expectedly low in μMT mice (Figure 4 B). In BAL fluid, μMT 
mice showed a tendency towards reduced IL-5 and IL-13 concentrations upon egg treatment 
similarly to WT animals, albeit not significant (suppl. Figure 4). The expression of Th2 
cytokines in supernatants of in vitro OVA-restimulated medLN cell cultures from WT mice 
was highly elevated in AAI mice and significantly reduced after egg treatment (Figure 5 C). 
Allergic μMT mice produced significantly less IL-5, IL-10 and IL-13 compared to their WT 
counterparts (Figure 4 C), like recently also shown in a house dust mite model of asthma 
(29). As expected, OVA-specific IgG1 and IgE antibodies in μMT mice remained at baseline 
values observed in naïve WT animals (Figure 4 D), excluding a major role of inhibitory 
antibodies in protection. These data show that B2 B cells, while contributing to Th2 cytokine 
production and the production of antigen-specific antibody responses, are not required for 
egg-mediated protection from AAI.  
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Egg treatment is associated with decreased recruitment of moDCs in the lung 
compartment 
Different studies have shown that helminths not only affect T and B cells, but can also 
mediate important effects by acting on DCs (30, 31). Pulmonary DCs play a central role in 
the immune response to allergens (32). Under steady state conditions, CD103
+
 and CD11b
+
 
conventional DC (cDC1 and cDC2, respectively) populations can be distinguished, whereas 
allergic inflammation triggers a strong influx of inflammatory, monocyte-derived DCs 
(moDCs) (33). Both CD11b
+
 cDC2 and moDCs can drive allergic Th2 responses in a model 
of HDM allergy, whereby moDCs were only sufficient in a high-dose HDM model of AAI 
(34). moDCs produce various chemokines and present allergen locally in the lung especially 
in a model of high-dose allergen exposure (34). Next we investigated whether prophylactic 
egg treatment alters the presence and function of different DC subsets in the lung of 
OVA/alum-allergic mice. The number of CD11c
+
 MHCII
+
 DCs strongly increased in allergic 
compared to control mice (Figure 5 A). Interestingly, egg treatment significantly impaired 
the number of lung DCs following challenge, whereas the total number of cells in the lung 
remained unaffected (Figure 5 A). The reduction in number of all CD11c
+
 MHCII
+
 DCs 
seems to be solely attributable to an abrogated expansion of the moDC compartment, as both 
the numbers of CD11b
+
 cDC2 and CD103
+
 cDC1s proved to be unaffected by egg treatment 
(Figure 5 B). Monocytes, which can differentiate into moDCs under inflammatory 
conditions, migrate in a CCR2/CCL2-dependant manner, whereas CD11b
+
 cDC2 and 
CD103
+
 cDC1s do not (34). We found the concentration of CCL2 in BAL fluid to be 
strikingly increased in allergic mice, and significantly reduced upon egg treatment (Figure 5 
C), providing an indication that the reduced number of moDCs in lung tissue is the result of 
reduced CCL2-mediated influx. 
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Discussion 
In this study we sought to further characterize the potential of S. mansoni to protect from 
allergic asthma, despite profound egg-specific Th2 responses, by using isolated S. mansoni 
eggs in a setting without adult worms. We show that S. mansoni eggs are capable of 
protecting against experimental AAI, which is in line with previous reports (16, 35) and in 
contrast to earlier work postulating that protection can only be achieved in the absence of 
female egg-laying worms. We found that protection from AAI can also be achieved by eggs 
isolated from infected mice instead of hamsters (data not shown), excluding confounding 
factors from contaminations of egg preparations with traces of hamster tissue. The data on 
administration of isolated eggs and the cellular mechanisms eggs can induce in the context of 
an allergic inflammation is still very limited. This study aims to advance the current 
knowledge as it provides new insight into the putative mechanism of protection in the 
presence of egg-specific Th2 responses.  
 
We show that egg treatment induces a fully developed Th2 response to egg antigens while  
the OVA-specific Th2 response, normally induced by alum, is completely absent. This is in 
line with earlier observations in chronic S. mansoni infections (14) and after treatment with 
excretory-secretory products of T. suis (36). Mangan et al. describe a “helminth-modified 
pulmonary Th2 response” in S. mansoni infection, characterized by elevated pulmonary IL-
10 and IL-13, but reduced IL-5 (13, 37). We found the production of OVA-specific Th2 
cytokines to be reduced upon egg treatment, which argues against a putative ‘modified Th2 
response’ in our egg-treatment model and is similar to what has been described in humans. 
People in schistosome-endemic areas, for which a negative association between chronic 
infection and allergic sensitization has been shown, often have elevated Th2 responses to the 
eggs alongside reduced allergic symptoms (7, 8). However, a recent study on a fishing 
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community in Uganda, with a low prevalence of allergy-related diseases, found a positive 
correlation between S. mansoni-specific Th2 cytokines and atopy, and S. mansoni-specific 
IgE and atopy, respectively. A significant inverse associations was observed in relation to 
wheeze, keeping with the original hypothesis (38). 
 
Previous reports describe Treg cells, Breg cells and IL-10 to be important for protection by 
natural infections (14, 16-19). We observed that the number of pulmonary Treg cells was 
increased in the BAL fluid of allergic mice during the challenge phase, which has similarly 
been reported by others (36, 39), but returns to baseline rather than continues to rise in treated 
animals. Following allergen challenge, egg-treated mice did not induce Treg cell numbers or 
enhance the expression of regulatory activity markers in the lung compartment compared to 
untreated, allergen-challenged mice. In addition, IL-10 in BAL fluid of egg-treated animals 
was unchanged following egg treatment. The fact that Treg cells did not exceed the baseline 
levels from naïve control mice combined with the lack of any activity markers suggests that 
there is no active suppression by Treg cells during the allergen challenge phase. Mice 
depleted of CD25-expressing Treg cells during egg treatment and allergic sensitization 
display a similar degree of AAI suppression, despite the inflammation being generally 
increased upon Treg depletion. Probably as a result of a dysregulated Treg to effector T cell 
balance, this suggests that egg-induced Treg cells do not play a decisive role in egg-induced 
protection from AAI in our hands. These findings seem, at least in part, contrary to a previous 
report on the putative role of Treg cells in a similar model of egg administration (16, 19).  
Discrepancies in the results may be related to factors like the length of exposure to parasitic 
products (infection versus isolated injections) or the use of different mouse strains. 
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To study the role of B cells in protection, we treated both WT and μMT mice with S. mansoni 
eggs. μMT mice lack mature, conventional B2 B cells (28). Most studies report that μMT 
mice mount an allergic response similar to their WT counterparts (40-42). In line with these 
data we also found the allergic response to be unaffected in μMT mice, apart from a 
significant reduction in the allergen-specific Th2 cytokine production by medLN cells. This 
could be, at least in part, due to the amount of allergen used, as we have previously reported 
an important role for B cells in low dose HDM-induced AAI (29). Despite the difference in 
OVA-specific Th2 responses, egg treatment equally protects from AAI both in WT and μMT 
mice, indicating that mature B cells are not crucial for protection. While this does not 
formally exclude a role for all Breg cell subsets, which can be present in both the B1 and B2 
B cell compartment (43-45), we believe they are unlikely to play a major role as we have 
previously studied the induction of Breg cells by S. mansoni infection, SEA and the single 
egg molecule IPSE/alpha-1, and predominantly identified Breg cells within the splenic 
marginal zone (MZ) B cell compartment as well as the pulmonary B cell compartment (46, 
47). Both MZ B cells, which belong to the B2 B cell lineage, and pulmonary B cells are 
absent in μMT mice and thus unlikely crucial for protection. Additionally, μMT mice are also 
unable to mount an allergen-specific antibody response (45), excluding a role of inhibitory 
antibodies in protection. 
 
DCs play a central role in the induction of adaptive immune responses in the context of AAI. 
Both CD11b
+
 cDCs and moDCs can drive allergic Th2 responses in a model of HDM allergy, 
with moDCs being sufficient in models of high-dose allergen exposure (34). Moreover, 
Schistosoma infection has been shown to functionally impair myeloid DCs in humans (30). 
Here, we show that during the challenge phase of OVA/alum-induced AAI control mice 
depict a sharp influx of moDCs, as well as increased numbers of CD103
+
 cDC1 and CD11b
+ 
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cDC2s. Interestingly, egg treatment selectively affects the lung moDC compartment, whereas 
both cDC populations remained unchanged. The reduced concentration of CCL2 in BAL 
fluid of egg-treated mice suggests that the recruitment of moDCs into the lung is impaired. 
During allergic sensitization with alum-supplemented allergen by i.p. injection, inflammatory 
monocytes are recruited to the peritoneal cavity within hours and ingest allergens in a uric 
acid-dependent manner. They migrate to the lung-draining medLNs and develop there into 
moDCs that contribute to the development of a Th2 response (48). It is unclear whether this 
inflammatory monocyte response to allergic sensitization in the peritoneal cavity was 
targeted by egg treatment or whether the reduced pulmonary moDC levels are the 
consequence of reduced inflammation and reduced CCL2 levels. Preliminary data suggest 
that moDCs isolated from allergic and egg-treated mice behave similar and both have a poor 
T cell stimulatory capacity (data not shown). This may suggest that the observed reduced 
number of moDCs is the consequence rather than the cause of reduced AAI in egg-treated 
mice. 
 
To date, a few single, immunomodulatory molecules from helminths have been identified, 
including ES-62 and Av17 from the filarial nematode Acanthocheilonema viteae (49, 50), 
AIP-2 from hookworms (51) as well as HpARI (52) and Hp-TGM (53) from H. polygyrus. 
For Schistosoma eggs, no immunomodulatory molecule has been characterized in a similar 
manner to date. The S. mansoni egg secretome has been described to contain 188 proteins 
(54). Some of these proteins have been shown to fulfil distinct functions (47, 55), whereas the 
role of others remains poorly characterized (56, 57). Cardoso et al. describe three single 
molecules, Sm22.6, PIII and Sm29 to all suppress allergic airway inflammation (26), all of 
which are not present in the egg stage of the life cycle. The only description of a Schistosoma 
ssp. egg-derived molecule inhibiting AAI is the S. japonicum molecule SjP40, which induces 
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IFN-γ production (58). As we find low levels of IFN-γ produced in response to the eggs, we 
do not expect that the S. mansoni homologue SmP40 mediates protection in our study. It will 
be the subject of future studies to identify single molecules secreted from S. mansoni eggs 
capable of modulating allergic asthma and further defining the immunological mechanism of 
suppression. To date, most studies have focussed on identifying single, egg-derived antigens 
as vaccine candidates rather than immunomodulatory agents (59). This study shows that, 
although eggs are inducers of a strong Th2 response, it is worthwhile to study the 
immunomodulatory capacities of egg-derived antigens.  
 
In summary, the here presented data show that the suppressive effect of S. mansoni infection 
on allergic asthma can be replicated by isolated eggs. This effect occurs despite a strong Th2 
response to the eggs itself and is likely independent of Treg and B cells during allergen 
challenge. Egg treatment strongly and selectively affects the lung moDC compartment. 
Understanding the complex interactions early during allergic sensitization - and how 
helminths interfere there – is critical for the development of preventative strategies for 
allergies and allergy-related diseases.  
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Figure legends 
Figure 1: S. mansoni eggs protect against OVA/alum-induced AAI. (A) Schematic 
representation of the experimental model. (B) Total number of cells, percentage of 
eosinophils and total number of eosinophils in BAL fluid as assessed by FACS. Summary of 
multiple experiments. (C) Total number of neutrophils (Neu), dendritic cells (DC), T cells 
and B cells in BAL fluid as assessed by FACS. Representative of multiple experiments, n=4-
5. (D) Representative images of haematoxylin and eosin (H&E) histology staining from PFA-
fixed sections (scale bar = 100µm). Scores for severity of cellular infiltration around the 
airways on a scale of 0-4 were assessed by two blinded observers. The average of both scores 
is displayed. Significant difference was determined by unpaired t-test, * p < 0.05. (E) OVA-
specific IgG1 and OVA-specific IgE antibodies in serum measured by ELISA. Representative 
of multiple experiments, n=4-5. (F) Cytokine concentration in BAL fluid measured by CBA. 
Representative of multiple experiments, n=4-5. (G) Cytokine concentration in medLN cell 
supernatants after 4d re-stimulation with OVA (10µg/mL) measured by CBA. Representative 
of multiple experiments, n=4-5. Significant differences were determined by two-way 
ANOVA following Tukey’s multiple comparison test (B) or one-way ANOVA following 
Dunnett’s multiple comparisons test (C-F) and are indicated with * p < 0.05, ** p < 0.01, *** 
p < 0.001.  
 
Figure 2: Protection occurs despite the induction of an egg-specific type 2 induction. (A, 
B) Cytokine concentration in spleen cell supernatants after 4d re-stimulation with SEA 
(10µg/mL; A) or OVA (10µg/mL; B). Representative of 2 experiments, n=3-4. (C) SEA-
specific IgG1 and SEA-specific IgE antibodies in serum measured by ELISA. Representative 
of 3 experiments, n=4-5. Significant differences were determined by one-way ANOVA 
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following Dunnett’s multiple comparisons test and are indicated with * p < 0.05, *** p < 
0.001.  
 
Figure 3: Regulatory T cells are not involved in egg-induced protection against AAI. (A, 
B) Percentage and total number of Foxp3
+
 CD25
+
 Treg cells in BAL fluid (A) and medLNs 
(B) assessed by FACS. Representative of multiple experiments, n=4-5. (C, D) Geometric 
mean expression of CTLA-4 and GITR on Foxp3
+
 CD25
+
 Treg cells in BAL fluid (C) and 
medLNs (D) assessed by FACS. Representative of multiple experiments, n=4-5. (E) 
Schematic representation of experimental model. (F) Total number of cells, percentage of 
eosinophils and total number of eosinophils in BAL fluid as assessed by FACS. 
Representative of 2 experiments, n=4-6. (G) Total number of neutrophils, dendritic cells 
(DCs), T cells and B cells in BAL fluid as assessed by FACS. Representative of 2 
experiments, n=4-6. (H) Cytokine concentration in BAL fluid measured by CBA. 
Representative of 2 experiments, n=4-6. Significant differences were determined by one-way 
ANOVA following Dunnett’s multiple comparisons test as indicated with * p < 0.05, ** p < 
0.01, *** p < 0.001, or by unpaired t-test as indicated by 
# 
p < 0.05.  
 
Figure 4: Mature B cells are not involved in egg-induced protection against AAI. (A) 
Total number of cells, percentage of eosinophils and total number of eosinophils in BAL 
fluid as assessed by FACS. (B) Total number of neutrophils, dendritic cells (DCs), T cells 
and B cells in BAL fluid as assessed by FACS. (C) Cytokine concentration in medLN cell 
culture supernatants after 4d re-stimulation with OVA (10µg/mL) measured by ELISA. (D) 
OVA-specific IgG1 and OVA-specific IgE antibodies in serum measured by ELISA. All data 
are a summary of 2 experiments, n=5-12. Significant differences were determined by one-
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way ANOVA following Dunnett’s multiple comparisons test as indicated with * p < 0.05, ** 
p < 0.01, *** p < 0.001, or by unpaired t-test as indicated by 
#
 p < 0.05, 
##
 p < 0.01.  
   
Figure 5: Egg treatment impairs the lung moDC, but not cDC, compartment. (A) Total 
number of lung cells, and total number of lung DCs (CD11c
+
 MHCII
+
), assessed by FACS. 
Representative of 2 experiments, n=4-6. (B) Total number of moDCs (CD11c
+
 MHCII
+
 
CD11b
+
 CD103
-
 CD64
+
), CD103
+
 cDC1 (CD11c
+
 MHCII
+
 CD11b
-
 CD103
+
 CD64
-
) and 
CD11b
+
 cDC2s (CD11c
+
 MHCII
+
 CD11b
+
 CD103
-
 CD64
-
) in the lung, assessed by FACS. 
Representative of 2 experiments, n=4-6. (C) Concentration of CCL2 in BAL fluid measured 
by CBA. Summary of 2 experiments, n=9-10. Significant differences were determined by 
one-way ANOVA following Dunnett’s multiple comparisons test and as indicated with * p < 
0.05, *** p < 0.001. 
 
Supplementary Figure 1: (A) Eggs were isolated from the liver of infected hamsters, 
washed extensively and either separated into immature and mature eggs following by culture, 
or frozen at -80°C prior to culture. Freshly isolated and freeze-thawed eggs were cultured at a 
density of 200.000 eggs/mL in medium for 48h before egg-free culture supernatant was 
collected and subjected to silver staining. (B) Total number of cells, percentage of 
eosinophils and total number of eosinophils in lung tissue  as assessed by FACS. 
Representative of 2 experiments, n=4-6.  (C) FACS gating strategy for the analysis of cells in 
BAL fluid. All single cells were gated for the identification of eosinophils (SiglecF
+
 CD11c
-
), 
alveolar macrophages (alvMFs; SiglecF
+
 CD11c
+
), neutrophils (SiglecF
-
 CD11c
-
 CD11b
+
 Gr-
1
+
) and DCs (SiglecF
-
 CD11c
+
 MHCII
+
). A lymphocyte gate was used to identify T cells 
(CD3
+
 B220
-
) and B cells (CD3
-
 B220
+
).  
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Supplementary Figure 2: Cytokine concentration in medLN cell supernatants after 4d re-
stimulation with SEA (10µg/mL), n=5. Significant differences were determined by one-way 
ANOVA following Dunnett’s multiple comparisons test and are indicated with *** p < 
0.001. 
 
Supplementary Figure 3: (A) Mice were treated with anti-CD25 depleting antibody (clone 
PC61) as described in Figure 4. Five days after the first antibody injection, tail blood was 
collected and the percentage of Foxp3
+ 
Treg cells of all CD4 T cells and of all cells assessed 
by FACS. Representative of two experiments, n=6. Significant differences were determined 
by one-way ANOVA following Dunnett’s multiple comparisons test and are indicated with 
*** p < 0.001. (B) FACS gating strategy for the analysis of Treg cells. Treg cells were 
identified as single, live CD3
+
 CD4
+
 Foxp3
+
 CD25
+
 cells. The geometric mean of 
fluorescence intensity was determined on all Treg cells.    
 
Supplementary Figure 4: Cytokine concentration in BAL fluid measured by ELISA, n=3-6. 
Significant differences were determined by one-way ANOVA following Dunnett’s multiple 
comparisons test and are indicated with * p < 0.05, ** p < 0.01.  
 
Supplementary Figure 5: FACS gating strategy for the analysis of DC subsets in lung 
tissue. Single, live cells were identified, and all SiglecF, CD3, CD19, NK1.1 and Gr-1 
expressing cells excluded. DCs were identified as CD11c
+
 MHCII
+
, and subdivided into 
CD103
+
 cDCs (CD103
+
 CD11b
-
 CD64
-
), CD11b
+
 cDCs (CD103
-
 CD11b
+
 CD64
-
) and 
moDCs (CD103
-
 CD11b
+
 CD64
+
).  
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